Related references
Note: Only part of the references are listed.Lessons from the RV144 Thai Phase III HIV-1 Vaccine Trial and the Search for Correlates of Protection
Jerome H. Kim et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model
Kristy Offerman et al.
BMC GENOMICS (2015)
Proof-of-Principle for Immune Control of Global HIV-1 Reactivation In Vivo
Nicola M. G. Smith et al.
CLINICAL INFECTIOUS DISEASES (2015)
Pre-Exposure Prophylaxis to Prevent HIV Infection: Current Status, Future Opportunities and Challenges
Douglas S. Krakower et al.
DRUGS (2015)
Increasing Complexity of Vaccine Development
Stanley A. Plotkin
JOURNAL OF INFECTIOUS DISEASES (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
HIV-1 assembly, release and maturation
Eric O. Freed
NATURE REVIEWS MICROBIOLOGY (2015)
The Influence of Immunization Route, Tissue Microenvironment, and Cytokine Cell Milieu on HIV-Specific CD8+T Cells Measured Using Fluidigm Dynamic Arrays
Shubhanshi Trivedi et al.
PLOS ONE (2015)
Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virus
John B. Schell et al.
VIROLOGY (2015)
Alternative Effector-Function Profiling Identifies Broad HIV-Specific T-Cell Responses in Highly HIV-Exposed Individuals Who Remain Uninfected
Marta Ruiz-Riol et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques
Nicola J. Borthwick et al.
IMMUNITY INFLAMMATION AND DISEASE (2015)
Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Vectors Prime for Strong Cellular Responses to Simian Immunodeficiency Virus Gag in Rhesus Macaques
Jaimie D. Sixsmith et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
Ending the Global HIV/AIDS Pandemic: The Critical Role of an HIV Vaccine
Anthony S. Fauci et al.
CLINICAL INFECTIOUS DISEASES (2014)
The novel Capripoxvirus vector lumpy skin disease virus efficiently boosts modified vaccinia Ankara human immunodeficiency virus responses in rhesus macaques
Wendy A. Burgers et al.
JOURNAL OF GENERAL VIROLOGY (2014)
CD40L-Adjuvanted DNA/Modified Vaccinia Virus Ankara Simian Immunodeficiency Virus SIV239 Vaccine Enhances SIV-Specific Humoral and Cellular Immunity and Improves Protection against a Heterologous SIVE660 Mucosal Challenge
Suefen Kwa et al.
JOURNAL OF VIROLOGY (2014)
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
Christopher J. L. Murray et al.
LANCET (2014)
Vaccine-elicited Human T Cells Recognizing Conserved Protein Regions Inhibit HIV-1
Nicola Borthwick et al.
MOLECULAR THERAPY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Vaccines that stimulate T cell immunity to HIV-1: the next step
Andrew J. McMichael et al.
NATURE IMMUNOLOGY (2014)
CD8 and CD4 Epitope Predictions in RV144: No Strong Evidence of a T-Cell Driven Sieve Effect in HIV-1 Breakthrough Sequences from Trial Participants
Kalpana Dommaraju et al.
PLOS ONE (2014)
Vaccine-Induced Env V1-V2 IgG3 Correlates with Lower HIV-1 Infection Risk and Declines Soon After Vaccination
Nicole L. Yates et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Achieving the HIV Prevention Impact of Voluntary Medical Male Circumcision: Lessons and Challenges for Managing Programs
Sema K. Sgaier et al.
PLOS MEDICINE (2014)
The influence of delivery vectors on HIV vaccine efficacy
Beatrice O. Ondondo
FRONTIERS IN MICROBIOLOGY (2014)
Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants incuce CD8+ T-regulatory cells that suppress SIV-positive CD4+ T-cell activation and prevent SIV infection in the macaque model
Jean-Marie Andrieu et al.
FRONTIERS IN IMMUNOLOGY (2014)
Rapid, complex adaptation of transmitted HIV-1 full-length genomes in subtype C-infected individuals with differing disease progression
Melissa-Rose Abrahams et al.
AIDS (2013)
Correlates of T-cell-mediated viral control and phenotype of CD8+ T cells in HIV-2, a naturally contained human retroviral infection
Thushan I. de Silva et al.
BLOOD (2013)
Virus-like particles produced in plants as potential vaccines
Nunzia Scotti et al.
EXPERT REVIEW OF VACCINES (2013)
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
Holly Janes et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Alternative Serotype Adenovirus Vaccine Vectors Elicit Memory T Cells with Enhanced Anamnestic Capacity Compared to Ad5 Vectors
Pablo Penaloza-MacMaster et al.
JOURNAL OF VIROLOGY (2013)
Quantitative and Qualitative Differences in the T Cell Response to HIV in Uninfected Ugandans Exposed or Unexposed to HIV-Infected Partners
Pietro Pala et al.
JOURNAL OF VIROLOGY (2013)
Robust Immunity to an Auxotrophic Mycobacterium bovis BCG-VLP Prime-Boost HIV Vaccine Candidate in a Nonhuman Primate Model
Gerald K. Chege et al.
JOURNAL OF VIROLOGY (2013)
Immune clearance of highly pathogenic SIV infection
Scott G. Hansen et al.
NATURE (2013)
Sensing and alarm function of resident memory CD8+ T cells
Jason M. Schenkel et al.
NATURE IMMUNOLOGY (2013)
Biological and biochemical characterization of HIV-1 Gag/dgp41 virus-like particles expressed in Nicotiana benthamiana
Sarah A. Kessans et al.
PLANT BIOTECHNOLOGY JOURNAL (2013)
Superior Control of HIV-1 Replication by CD8+T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design
Pratima Kunwar et al.
PLOS ONE (2013)
Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells
Robert W. Buckheit et al.
RETROVIROLOGY (2013)
HIV-Specific CD4 T Cell Responses to Different Viral Proteins Have Discordant Associations with Viral Load and Clinical Outcome
Srinika Ranasinghe et al.
JOURNAL OF VIROLOGY (2012)
Full-Length HIV-1 Immunogens Induce Greater Magnitude and Comparable Breadth of T Lymphocyte Responses to Conserved HIV-1 Regions Compared with Conserved-Region-Only HIV-1 Immunogens in Rhesus Monkeys
Kathryn E. Stephenson et al.
JOURNAL OF VIROLOGY (2012)
HIV-1 Virus-Like Particles Produced by Stably Transfected Drosophila S2 Cells: a Desirable Vaccine Component
Lifei Yang et al.
JOURNAL OF VIROLOGY (2012)
Inhibitory Potential of Subpopulations of CD8+ T Cells in HIV-1-Infected Elite Suppressors
Robert W. Buckheit et al.
JOURNAL OF VIROLOGY (2012)
A vaccine strategy that protects against genital herpes by establishing local memory T cells
Haina Shin et al.
NATURE (2012)
Inhibition of cell-associated HIV-1 by silver nanoparticles
Dinesh K. Singh et al.
RETROVIROLOGY (2012)
A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge
Matthew R. Reynolds et al.
VACCINE (2012)
Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens
Sampa Santra et al.
VIROLOGY (2012)
Stability studies of HIV-1 Pr55gag virus-like particles made in insect cells after storage in various formulation media
Alisson Lynch et al.
VIROLOGY JOURNAL (2012)
Induction of CD8+ Regulatory T Cells Protects Macaques against SIV Challenge
Wei Lu et al.
CELL REPORTS (2012)
Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine
Michael Hellerstein et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection
Andrew Prendergast et al.
AIDS (2011)
Human immunodeficiency virus type 1 long-term non-progressors: the viral, genetic and immunological basis for disease non-progression
Kate Poropatich et al.
JOURNAL OF GENERAL VIROLOGY (2011)
Mosaic HIV-1 Gag Antigens Can Be Processed and Presented to Human HIV-Specific CD8+ T Cells
Zaza M. Ndhlovu et al.
JOURNAL OF IMMUNOLOGY (2011)
Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
Scott G. Hansen et al.
NATURE (2011)
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects
Michael C. Keefer et al.
VACCINE (2011)
Abrogation of contaminating RNA activity in HIV-1 Gag VLPs
Ziyaad Valley-Omar et al.
VIROLOGY JOURNAL (2011)
HIV-specific CD4 T cells and immune control of viral replication
Filippos Porichis et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Elite controllers as a model of functional cure
Brigitte Autran et al.
CURRENT OPINION IN HIV AND AIDS (2011)
Use of the piggyBac transposon to create HIV-1 gag transgenic insect cell lines for continuous VLP production
Alisson G. Lynch et al.
BMC BIOTECHNOLOGY (2010)
Immune-based Approaches to the Prevention of Mother-to-child Transmission of HIV-1: Active and Passive Immunization
Barb Lohman-Payne et al.
CLINICS IN PERINATOLOGY (2010)
Recombinant Mycobacterium bovis BCG as an HIV Vaccine Vector
Rosamund Chapman et al.
CURRENT HIV RESEARCH (2010)
Efficacy of Multivalent Adenovirus-Based Vaccine against Simian Immunodeficiency Virus Challenge
Danilo R. Casimiro et al.
JOURNAL OF VIROLOGY (2010)
Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
Sampa Santra et al.
NATURE MEDICINE (2010)
Optimization of Chimeric HIV-1 Virus-Like Particle Production in a Baculovirus-Insect Cell Expression System
Sirika Pillay et al.
BIOTECHNOLOGY PROGRESS (2009)
Broad, high-magnitude and multifunctional CD4+ and CD8+ T-cell responses elicited by a DNA and modified vaccinia Ankara vaccine containing human immunodeficiency virus type 1 subtype C genes in baboons
Wendy A. Burgers et al.
JOURNAL OF GENERAL VIROLOGY (2009)
HIV-1-Specific Cytotoxic T Lymphocytes and Breast Milk HIV-1 Transmission
Grace C. John-Stewart et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Antiviral CD8(+) T cells in the genital tract control viral replication and delay progression to AIDS after vaginal SIV challenge in rhesus macaques immunized with virulence attenuated SHIV 89.6
M. Genesca et al.
JOURNAL OF INTERNAL MEDICINE (2009)
Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location
D. Masopust
JOURNAL OF INTERNAL MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
Nunzia Scotti et al.
PLANTA (2009)
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines
Sean P. McBurney et al.
VACCINE (2009)
A prime-boost immunisation regimen using recombinant BCG and Pr55gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons
Gerald K. Chege et al.
VACCINE (2009)
Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C
Wendy A. Burgers et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Correlates of vaccine-induced immunity
Stanley A. Plotkin
CLINICAL INFECTIOUS DISEASES (2008)
An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
Alexandre Harari et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
HIV-1 subtype CPr55gag virus-like particle vaccine efficiently boosts baboons primed with a matched DNA vaccine
Gerald K. Chege et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy
Florencia Pereyra et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency
Monica Vaccari et al.
JOURNAL OF VIROLOGY (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads
Morgane Rolland et al.
PLOS ONE (2008)
Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles
Richard J. Halsey et al.
VIRUS RESEARCH (2008)
Wanted: correlates of vaccine-induced protection against simian immunodeficiency virus
Thomas C. Friedrich et al.
CURRENT OPINION IN HIV AND AIDS (2008)
Robust gag-specific T cell responses characterize viremia control in HIV-2 infection
Aleksandra Leligdowicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Will Fischer et al.
NATURE MEDICINE (2007)
Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses
L. Buonaguro et al.
JOURNAL OF VIROLOGY (2006)
Stimulation history dictates memory CD8 T cell phenotype: Implications for prime-boost vaccination
David Masopust et al.
JOURNAL OF IMMUNOLOGY (2006)
Viral diversity as a challenge to HIV-1 vaccine development
Jean K. Carr
CURRENT OPINION IN HIV AND AIDS (2006)
Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag
DR Casimiro et al.
JOURNAL OF VIROLOGY (2005)
Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity
Y Ami et al.
JOURNAL OF VIROLOGY (2005)
Comparative immunogenicity in rhesus monkeys of multi-protein HIV-1 (CRF02_AG) DNA/MVA vaccines expressing mature and immxature VLPs
D Ellenberger et al.
VIROLOGY (2005)
Recombinant HIV-1 Pr55gag virus-like particles:: potent stimulators of innate and acquired immune responses
L Deml et al.
MOLECULAR IMMUNOLOGY (2005)
CD8(+) T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses
G Arrode et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice
A Jaffray et al.
JOURNAL OF GENERAL VIROLOGY (2004)
DNA/MVA vaccine for HIV type 1: Effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime
JM Smith et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Construction and characterisation of a candidate HIV-1 subtype C DNA vaccine for South Africa
JH van Harmelen et al.
VACCINE (2003)
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development
C Williamson et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2003)
Chimeric human papilloma virus-simian/human immunodeficiency virus virus-like-particle vaccines: Immunogenicity and protective efficacy in macaques
CJ Dale et al.
VIROLOGY (2002)
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
JW Shiver et al.
NATURE (2002)
Characterization of full-length HIV type 1 subtype C sequences from South Africa
J van Harmelen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers
R Kaul et al.
IMMUNOLOGY LETTERS (2001)
Induction of neutralizing antibodies and gag-specific cellular immune responses to an R5 primary isolate of human immunodeficiency virus type 1 in rhesus macaques
DC Montefiori et al.
JOURNAL OF VIROLOGY (2001)
Evolutionary and immunological implications of contemporary HIV-1 variation
B Korber et al.
BRITISH MEDICAL BULLETIN (2001)
High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A
L Buonaguro et al.
ANTIVIRAL RESEARCH (2001)
Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques
X Paliard et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
Share Paper
